Last Updated: May 20, 2016
- Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer.
Roh Seon Ae, et al. Journal of cancer research and clinical oncology 2016 5 - Fc-? Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.
Liu Geoffrey, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 5 (10) 2435-44 - Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer?
Cragun Deborah et al. Journal of genetic counseling 2015 Jun 24(3) 409-20 - Creation of a network to promote universal screening for Lynch syndrome: the LynchSyndrome Screening Network.
Mange Sarah et al. Journal of genetic counseling 2015 Jun 24(3) 421-7 - Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
Kallenberg F G J et al. Alimentary pharmacology & therapeutics 2016 May - Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases.
George Rani et al. Journal of genetic counseling 2015 Jun 24(3) 388-99 - Genetic Instability in Locus rs5498 E469K (A/G) of ICAM-1 Gene in Patients with Colorectal Cancer and Breast Cancer.
Novikov V V, et al. Bulletin of experimental biology and medicine 2016 5 - Molecular analysis of MLH1 variants in Chinese sporadic colorectal cancer patients.
Peng H X, et al. Genetics and molecular research : GMR 2016 0 (2) - Identification of a functional variant for colorectal cancer risk mapping to chromosome 5q31.1.
Ke Juntao, et al. Oncotarget 2016 5 - The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.
Esteban-Jurado Clara, et al. European journal of human genetics : EJHG 2016 5 - Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer.
Suraweera Nirosha, et al. Oncotarget 2016 4 - Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer.
Larsson Anna H, et al. Journal of translational medicine 2016 0 (1) 128 - A novel genetic score model of UGT1A1 and TGFB pathway as predictor of severe irinotecan-related diarrhea in metastatic colorectal cancer patients.
Li Jing, et al. Journal of cancer research and clinical oncology 2016 5 - Clinicopathological features of familial adenomatous polyposis in Korean patients.
Jung Sung Min, et al. World journal of gastroenterology 2016 5 (17) 4380-8 - Association of mitochondrial displacement loop polymorphisms with risk of colorectal cancer in south Indian population.
Govatati Suresh, et al. Mitochondrial DNA. Part A. DNA mapping, sequencing, and analysis 2016 3 1-6 - [KRAS mutation does not influence oxaliplatin or irinotecan efficacy, in association with bevacizumab, in first line treatment of metastatic colorectal cancer].
Cabart Mathilde, et al. Bulletin du cancer 2016 5 - Systematic screening for Lynch syndrome in colorectal cancer,
Swiss Med Wkly. 2016;146:w14315v - Systematic immunohistochemical screening for Lynch syndrome in colorectal cancer: a single centre experience of 486 patients.
Zumstein Valentin, et al. Swiss medical weekly 2016 0 w14315 - Determinants of non-participation in a mass screening program for colorectal cancer in Finland.
Artama M, et al. Acta oncologica (Stockholm, Sweden) 2016 5 1-5 - Associations between markers of colorectal cancer stem cells, mutation, miRNA and the clinical features of ulcerative colitis.
Yang Liu, et al. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2016 5 - Polymorphisms in the CHIT1 gene: Associations with colorectal cancer.
Li Fei-Feng, et al. Oncotarget 2016 5 - (18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status.
Lovinfosse Pierre, et al. The British journal of radiology 2016 5 20160212 - Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples.
Dallol Ashraf, et al. Journal of translational medicine 2016 0 (1) 118 - Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer.
He Qiong, et al. OncoTargets and therapy 2016 0 2329-35 - Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials.
Zhu Lizhen, et al. PloS one 2016 0 (5) e0154795 - A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.
Garrity-Park Megan M, et al. Inflammatory bowel diseases 2016 4 - JAX Genomics Education: Cancer Risk Assessment, Testing & Management
Disease: Lynch syndrome|Breast Cancer|Ovarian Cancer; Type: Education; State: Multiple States - Microsatellite instability and BRAF mutation in colorectal cancer: clinicopathological characteristics and effects on survival.
Batur Sebnem, et al. Bosnian journal of basic medical sciences / Udruzenje basicnih mediciniskih znanosti = Association of Basic Medical Sciences 2016 4 - Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study.
Quintero Enrique et al. PLoS medicine 2016 May 13(5) e1002008 - Barriers and Facilitators to Adoption of Genomic Services for Colorectal Care within the Veterans Health Administration.
Sperber Nina R et al. Journal of personalized medicine 6(2)
- Human (0)
- Pathogen (5)
- Human (3937)
- Pathogen (0)
- Human (208)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario